Money Map Press

LOG IN

Forgot Password?

Forgot Password?

  • Learn More

    Links

    • About Money Map Press
    • Our Experts
    • Testimonials
    • FAQ
    • Contact Us
    • Brokerage Firms
    • Money Map Press Glossary
Login

LOG IN

Forgot Password?

Forgot Password?

Learn More
  • About Money Map Press
  • Our Experts
  • Testimonials
  • FAQ
  • Contact Us
  • Brokerage Firms
  • Money Map Press Glossary
Search

Ernie Tremblay

Once singled out as the “most winning” stock-picker in the investment newsletter industry, Ernie Tremblay has more than 25 years of experience in following and analyzing the latest developments in health, medicine, and related technologies.

But his background isn’t in stock-picking at all.

As a health editor and writer, Ernie has contributed to more than 100 publications on topics like diabetes, Alzheimer’s disease, arthritis, dermatology, and groundbreaking medical therapies, for top publishers such as Prentice Hall, Harper Collins, and others. Over the decades, Ernie has gained “insider” access to some of the world’s top medical professionals, including Nobel-caliber doctors like Yale’s Karel Liem, Columbia’s George Gaylord Simpson, and Harvard’s William S. Beck.

Ernie understands the FDA approval process, as well as the “hard science” behind new, experimental drugs and the market demand for them – and has a comprehensive grasp of the complex dynamics that determine whether a new drug will be a breakthrough winner, or just another casualty of the FDA approval process.

So, when Ernie turned his attention to the biotech investing world, he discovered what everybody was getting wrong – What every other “expert” analyst didn’t know.

It’s the simplest question on earth: Does the science behind the drug work?

When you can master that one simple question (and no one else can), you can get extremely rich. Ernie proved that almost right away.

In 2012, after years of calibration and testing, Ernie started publishing his recommendations exclusively for Money Map members, using a proprietary Three-Phase System that identifies the next “blockbuster” drugs and determines whether upcoming regulatory events will make a stock rocket skyward or plunge in the opposite direction. Most remarkably, he maintains a calendar that shows when the gains will come, down to the day.

His very first recommendation was a “buy” on a small-cap biotech called Aegerion Pharmaceuticals Inc. (AEGR). The company was developing a new orphan drug to treat a rare, fatal blood disease in young adults. Ernie was convinced it was a winner.

In October 2012, when the stock was $17/share, he wrote to members:

“[I] put the potential share price of this company at just shy of $72 per share. Based on the current share price – that represents a potential first-year gain of over 360%.”

As it turned out, the stock delivered a 346% total return for members in just eight months – four months ahead of schedule.

Today Ernie still uses this very same system to track the best profit opportunities for his Biotech Insider Alert members. He also contributes to Money Morning as the biotech investing specialist.

Reviews for Ernie Tremblay

To find out more about Ernie and his publications, click on the links below.
Ernie Tremblay
Biotech Insider Alert

Ernie Tremblay Writes In:

Biotech Insider AlertBiotech investing expert Ernie Tremblay has built a powerful three-phase formula that can accurately determine whether a new drug will be a breakthrough winner – or a casualty of an FDA denial. And once a drug has passed his rigorous evaluation, Ernie pinpoints the exact calendar date the pharmaceutical company behind a new therapy can skyrocket in value, popping by double and triple digits overnight, then running up to even bigger gains in the months ahead. Learn More

Need help?

  • Home
  • Contact VIP Trading Specialists
  • Contact Customer Service
  • Passport Club Concierge
  • Training Center
  • Browse Your Subscriptions

Recent Reviews

Thus far, your service is the best value I’ve come across in the 30 years I’ve been investing and trading. A hearty Thank You! — Dr. Harold Parker
I racked up $12.46/share in profit on average. Very decisive win and truly impressive recommendation. So I make that out, exclusive of commissions and exchange fees, as a 79.5% rate of return over 22 days! Thank you very much. — Richard Stiles
Read All Reviews

Ernie Tremblay Writes In:

  • Biotech Insider Alert

Newsletters

  • High Velocity Windfalls
  • The 10-Minute Millionaire Insider
  • Fast Fortune Club
  • Nova-X Report
  • Private Briefing
  • Money Map Report
  • Energy Advantage

Trading Services

  • BetaFlow
  • Shockwave Trader
  • V3 Trader
  • Straight Line Profits
  • Money Calendar Pro
  • High Velocity Profits
  • Stealth Profits Trader
  • Biotech Insider Alert
  • Radical Technology Profits
  • Energy Inner Circle

Elite Services

  • The 1450 Club
  • Quantum Windfall Alert
  • Daily Flash Cash
  • 10X Trader
  • Alpha-9 Trader
  • Heatseekers
  • The Money Zone
  • Cryptocurrency Windfalls
  • Night Trader
  • Weekly Cash Clock
  • Micro Energy Trader

Memberships

  • Rapid-Fire Profits Alliance
  • Tom Gentile's Trading Circle
  • Money Map Resource Network
  • Black Diamond
  • Passport Fellowship
  • Passport Club
logo (light)
Get it on Google Play

© 2019 – Money Map Press

1125 N Charles Street | Baltimore, MD, 21201 | USA

Toll-free 1.888.384.8339 | International +1.443.353.4519 | Fax 1.410.622.3050

  • Site Map
  • Privacy Policy
  • Contact Us
  • About Money Map Press
  • Terms & Conditions
Connect:
MoneyMapPress
×
Browse Your Subscriptions

Contact Customer Service

Please fill out the form below and one of our customer service representatives will be in touch shortly.

Helpful Links

  • Update Username / Password
  • Special Reports
  • How to download Special Reports
  • Update Contact Information
  • Subscription Status
  • Subscription Expiration
  • Tips to receive our emails
  • Question for Editors
  • Find Broker
  • Investing Tips
  • Options Trading

Customer Service
Toll-free: 1.888.384.8339
Intl: +1.443.353.4519
Fax: 1.410.622.3050

Contact Our VIP Trading Service Specialist

The Money Map Press VIP Trading Service Specialists team is available Monday - Friday between 8:00 AM and 7:00 PM ET.

By Phone:
Toll-Free: 855.509.6600
Local/International: 410.622.3004

Helpful Links

  • Update Username / Password
  • Special Reports
  • How to download Special Reports
  • Update Contact Information
  • Subscription Status
  • Subscription Expiration
  • Tips to receive our emails
  • Question for Editors
  • Find Broker
  • Investing Tips
  • Options Trading

Customer Service
Toll-free: 1.888.384.8339
Intl: +1.443.353.4519
Fax: 1.410.622.3050

Ask a question.

Helpful Links

  • Update Username / Password
  • Special Reports
  • How to download Special Reports
  • Update Contact Information
  • Subscription Status
  • Subscription Expiration
  • Tips to receive our emails
  • Question for Editors
  • Find Broker
  • Investing Tips
  • Options Trading

Customer Service
Toll-free: 1.888.384.8339
Intl: +1.443.353.4519
Fax: 1.410.622.3050

To get immediate answers to commonly asked questions, click here.
*
*
*
Select a Publication:
Select a Topic: *
*
Comments:

Click here to visit Reset Password Page

Create New Topic

*
*
Select a Publication:
*

Contact Concierge

The Money Map Press' Concierge is available Monday - Friday between 8:00 AM and 5:00 PM ET.

Toll-Free: 1.800.682.1359
Local/International: 1.443.384.8339

Sales Copy

Access to Biotech Insider Alert is Reserved for Paid Subscribers

To get immediate access to the latest…

MARKET UPDATES
Biotech Insider Alert analyzes upcoming FDA actions to discover which ones will drive a company’s stock to new heights long before the mainstream financial press notices. He also consults with highly respected medical and scientific experts to separate the ground-breaking discoveries from the “me too” drugs and medical devices.

THE THREE-PHASE FORMULA
Every recommendation must meet three critical tests: The science must work. The market must be hungry. Timing is everything. This strategy pinpoints medical discoveries that the market is waiting for.

ERNIE’S EXPERTISE
Biotech Insider Alert uses Ernie’s over 20 years’ experience studying and writing about the latest developments in health, medicine, and related technologies. He understands the FDA approval process, the “hard science” behind these drugs, and the market demand for them, better than almost anyone else on earth.

You can subscribe to the Biotech Insider Alert here.

Current members can log in at the top of this page.

You must be logged in to view the Biotech Insider Alert Portfolio

The Biotech Insider Alert portfolio is driven by Ernie’s “Secret Calendar” – a tool he developed to track the most important catalysts for biotech, pharmaceutical, and medical device stocks. There are over 140 “calendar dates” scheduled for drugs and devices already in 2015 – with more being added all the time. The trick is knowing which ones will be big winners and which ones will fall flat on their faces.

Since the launch Biotech Insider Alert readers have scored a 71% win rate, with 10 double-digit gains.

Go here for immediate access to the Biotech Insider Alert portfolio

Current members can log in at the top of this page.

You must be logged in to view Biotech Insider Alert Alerts

Each week, Biotech Insider Alert readers receive a full update on every position in the portfolio along with special updates on how FDA actions are impacting your investments.

Since launching, Biotech Insider Alert readers have scored a 71% win rate, with 10 double-digit gains.

Go here for immediate access to Biotech Insider Alert portfolio updates.

Current members can log in at the top of this page.

You must be logged in to view exclusive Biotech Insider Alert investor briefings.

The Biotech Insider Alert library includes Ernie Tremblay’s in-depth research reports that not only provide comprehensive analysis, but an explanation of key biotech terms and concepts. You’ll also find Ernie’s proprietary Three-Phase Formula that drives his success.

Go here for immediate access to Biotech Insider Alert investor briefings.

Current members can log in at the top of this page.

Access to Biotech Insider Alert is Reserved for Paid Subscribers

To give Biotech Insider Alert Members the most in-depth and up-to-date information on promising biotech companies, Ernie will arrange and record members-only conference calls. Access the recordings to hear Ernie cover the latest on current Portfolio recommendations, discuss upcoming Catalyst dates, and answer questions from Members.

You can subscribe to the Biotech Insider Alert here.

Current members can log in at the top of this page.

Ask a question.

Subscribe to

You clicked on:

Invalid Username or Password

OK